The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“Multidrug resistance is also emerging as the major problem in the conventional treatment of cancer [3].”
BackgroundPI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,443
Kunnumakkara, A. B., Anand, P., & Aggarwal, B. B. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.009 · Cited by 1,073
Anti-cancer natural products isolated from chinese medicinal herbs
Tan, W., Lu, J., Huang, M., Li, Y., Chen, M., Wu, G., Gong, J., Zhong, Z., Xu, Z., Dang, Y., et al. (2011) · Chinese Medicine · doi:10.1186/1749-8546-6-27 · Cited by 396
Pickhardt, M., Gazova, Z., von Bergen, M., Khlistunova, I., Wang, Y., Hascher, A., Mandelkow, E.-M., Biernat, J., & Mandelkow, E. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410984200 · Cited by 333
Su, Y.-T., Chang, H.-L., Shyue, S.-K., & Hsu, S.-L. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.026 · Cited by 255
Chen, Y.-C., Shen, S.-C., Lee, W.-R., Hsu, F.-L., Lin, H.-Y., Ko, C.-H., & Tseng, S.-W. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01386-2 · Cited by 226
Srinivas, G., Anto, R. J., Srinivas, P., Vidhyalakshmi, S., Senan, V. P., & Karunagaran, D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01976-9 · Cited by 192
Emodin Down-Regulates Androgen Receptor and Inhibits Prostate Cancer Cell Growth
Cha, T.-L., Qiu, L., Chen, C.-T., Wen, Y., & Hung, M.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3250 · Cited by 178
Kumar, A., Dhawan, S., & Aggarwal, B. B. (1998) · Oncogene · doi:10.1038/sj.onc.1201998 · Cited by 163
Self-citationZhang, L., Chang, C., Bacus, S. S., & Hung, M. (1995) · PubMed · Cited by 162
Müller, S. O., Eckert, I., Lutz, W. K., & Stopper, H. (1996) · Mutation Research/Genetic Toxicology · doi:10.1016/s0165-1218(96)90105-6 · Cited by 158
Zhang, L., Lau, Y. K. J., Xia, W., Hortobágyi, G. N., & Hung, M. (1999) · PubMed · Cited by 150
Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells
Shieh, D., Chen, Y.-Y., Yen, M., Chiang, L., & Lin, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.060 · Cited by 150
Subramaniam, A., Shanmugam, M. K., Ong, T. H., Li, F., Perumal, E., Chen, L., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12302 · Cited by 147
Self-citationHuang, Q. B., Shen, H., & Ong, C. N. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.03.032 · Cited by 142
Muto, A., Hori, M., Sasaki, Y., Saitoh, A., Yasuda, I., Maekawa, T., Uchida, T., Asakura, K., Nakazato, T., Kaneda, T., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0605 · Cited by 132
Manu, K. A., Shanmugam, M. K., Rajendran, P., Li, F., Ramachandran, L., Hay, H. S., Kannaiyan, R., Swamy, S. N., Vali, S., Kapoor, S., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-107 · Cited by 126
Self-citationMa, Y., Weng, S.-W., Lin, M.-W., Lu, C., Chiang, J., Yang, J., Lai, K., Lin, J.-P., Nou-Ying, T., Lin, J.-G., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.01.033 · Cited by 125
Kuo, Y., Meng, H.-C., & Tsai, W.-J. (2001) · Inflammation Research · doi:10.1007/s000110050727 · Cited by 125
Kwak, H., Park, M., Park, C., Moon, S., Yoo, D., Lee, H., Lee, S., Kim, M., Lee, H., Shin, W., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21641 · Cited by 125
Zhang, L., & Hung, M. (1996) · PubMed · Cited by 113
Chun-Guang, W., Yang, J., Liu, B., Dan-ting, J., Wang, C., Zhong, L., Zhu, D., & Yan, W. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.035 · Cited by 112
Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma
Lee, H. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704205 · Cited by 110
Lin, S.-Y., Lai, W.-W., Ho, C.-C., Yu, F.-S., Chen, G.-W., Yang, J., Liu, K.-C., Lin, M., Wu, P.-P., Fan, M., et al. (2009) · PubMed · Cited by 109
Targeting HER2: Recent developments and future directions for breast cancer patients
Wang, S.-C., Zhang, L., Hortobágyi, G. N., & Hung, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90105-8 · Cited by 104
Huang, X., Wang, J., Huang, C., Chen, Y., Shi, G., Hu, Q.-S., & Yi, J. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.3.5457 · Cited by 103
Lu, Y., Yang, J., Li, X., Hwangbo, K., Hwang, S., Taketomi, Y., Murakami, M., Chang, Y., Kim, C., Son, J., et al. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.022 · Cited by 101
Lin, S., Wei, W., Chen, H., Chen, K., Tong, H., Wang, Z., Ni, Z., Liu, H., Guo, H., & LIU, D.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042146 · Cited by 94
Hsu, C.-M., Hsu, Y.-A., Tsai, Y., Shieh, F., Huang, S., Wan, L., & Tsai, F. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.153 · Cited by 94
Meng, G., Liu, Y., Lou, C.-C., & Yang, H. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00993.x · Cited by 92
Ha, M.-K., Song, Y. H., Jeong, S., Lee, H., Jung, J. H., Kim, B., Song, H. S., Huh, J., & Kim, S. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1432 · Cited by 91
Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin
Jing, X., Ueki, N., Cheng, J., Imanishi, H., & Hada, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb01332.x · Cited by 91
Neuroprotective effects of emodin in rat cortical neurons against β-amyloid-induced neurotoxicity
Liu, T., Jin, H., Sun, Q., Xu, J., & Hu, H. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.079 · Cited by 89
Yan, Y., Su, X., Liang, Y.-J., Zhang, J., Shi, C., Lu, Y., Gu, L.-Q., & Fu, L. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2362 · Cited by 89
Self-citationCharacterization of the genotoxicity of anthraquinones in mammalian cells
Mueller, S. O., & Stopper, H. (1999) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(99)00064-1 · Cited by 88
Wu, Y., Tu, X., Lin, G., Xia, H., Huang, H., Wan, J., Cheng, Z., Liu, M., Chen, G., Zhang, H., et al. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.040 · Cited by 83
Li, Y., Luan, Y., Qi, X., Li, M., Gong, L., Xue, X., Wu, X., Wu, Y., Chen, M., Xing, G., et al. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq282 · Cited by 81
Liu (2009) · Oncology Reports · doi:10.3892/or_00000394 · Cited by 78
Lai, J.-M., Chang, J. T., Wen, C.-L., & Hsu, S. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.08.031 · Cited by 77
Manu, K. A., Shanmugam, M. K., Ong, T. H., Subramaniam, A., Siveen, K. S., Perumal, E., Samy, R. P., Bist, P., Lim, L. H. K., Kumar, A. P., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057015 · Cited by 72
Self-citationYang, J., Li, H., Chen, Y., Wang, X., Shi, G., Hu, Q.-S., Kang, X., Lü, Y., Tang, X., Guo, Q.-S., et al. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.016 · Cited by 70
ほ乳動物細胞における下剤成分エモジン,アロエ-エモジン及びダントロンの遺伝毒性 トポイソメラーゼIIの介在か
Mueller, S. O., Eckert, I., Lutz, W. K., & Stopper, H. (1996) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · Cited by 69
Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Kim, M. S., Park, M. J., Kim, S. J., Lee, C. H., Yoo, H., Shin, S. H., Song, E. S., & Lee, S. H. (2005) · PubMed · Cited by 67
Emodin and rhein inhibit LIGHT-induced monocytes migration by blocking of ROS production
Heo, S., Yun, H., Noh, E., et al. (2010) · Vascular Pharmacology · doi:10.1016/j.vph.2010.03.002 · Cited by 66
Chu, X., Wei, M., Yang, X., Cao, Q., Xie, X., Guan, M., Wang, D., & Deng, X. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.03.076 · Cited by 62
Li, Z., Xia, X., Zhang, S., Zhang, A., Bo, W., & Zhou, R. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.01.003 · Cited by 57
Ko, J., Su, Y.-J., Lin, S.-T., Jhan, J.-Y., Ciou, S., Cheng, C., Chiu, Y., Kuo, Y., Tsai, M., & Lin, Y. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.10.013 · Cited by 56
Guo, Q., Chen, Y., Zhang, B., Kang, M., Xie, Q., & Wu, Y. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.021 · Cited by 56
Emodin induces apoptosis in human prostate cancer cell LNCaP
Yu, C., Zhang, X.-Q., Kang, L.-D., Zhang, P., Chen, W., Liu, W.-W., Liu, Q., & Zhang, J. (2008) · Asian Journal of Andrology · doi:10.1111/j.1745-7262.2008.00397.x · Cited by 55
Self-citationEmodin Regulates Apoptotic Pathway in Human Liver Cancer Cells
Yu, J. J., Bao, W., & Lei, J. (2012) · Phytotherapy Research · doi:10.1002/ptr.4703 · Cited by 54
Olsen, B. B., Bjørling-Poulsen, M., & Guerra, B. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.006 · Cited by 54
Heo, S., Yun, H., Park, W., & Park, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21805 · Cited by 53
Yan, Y., Zheng, L.-S., Zhang, X., Chen, L.-K., Singh, S., Wang, F., Zhang, J., Liang, Y.-J., Dai, C.-L., Gu, L., et al. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000499 · Cited by 50
Self-citationThe Effect of Emodin on VEGF Receptors in Human Colon Cancer Cells
Lu, Y., Zhang, J., & Qian, J. (2008) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2007.0425 · Cited by 48
Self-citationOk, S., Kim, S., Kim, C., Nam, D., Shim, B. S., Kim, S., Ahn, K. S., Choi, S., & Ahn, K. S. (2012) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2012.654494 · Cited by 47
Self-citationEmodin inhibits TNF α-induced MMP-1 expression through suppression of activator protein-1 (AP-1)
Lee, J., Jung, E., Lee, J., Huh, S., Hwang, C.-H., Lee, H.-Y., Kim, E., Cheon, J.-M., Hyun, C. G., Kim, Y. S., et al. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.08.008 · Cited by 47
Emodin Promotes Atherosclerotic Plaque Stability in Fat-Fed Apolipoprotein E-Deficient Mice
Zhou, M., Xu, H., Pan, L., Wen, J., Guo, Y., & Chen, K. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.215.61 · Cited by 41
Emodin promoted pancreatic claudin-5 and occludin expression in experimental acute pancreatitis rats
Xia, X., Bang-ku, L., Xing, S.-M., & Ruan, H.-L. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i17.2132 · Cited by 36
Masaldan, S., & Iyer, V. V. (2012) · Journal of Applied Toxicology · doi:10.1002/jat.2838 · Cited by 33
Emodin, a Naturally Occurring Anthraquinone, Ameliorates Experimental Autoimmune Myocarditis in Rats
Song, Z.-C., Wang, Z.-S., Bai, J., Zhao, L., & Hu, J. P. (2012) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.227.225 · Cited by 32
Sun, Z., & Bu, P. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.516 · Cited by 31
Emodin induces Panc-1 cell apoptosis via declining the mitochondrial membrane potential
LIU, J.-X., ZHANG, J.-H., Li, H., LAI, F.-J., Chen, K., Chen, H., Jiang, L., Guo, H., Wang, Z., & Lin, S. (2012) · Oncology Reports · doi:10.3892/or.2012.2042 · Cited by 31
Self-citationEmodin-6-O-β-d-glucoside inhibits HMGB1-induced inflammatory responses in vitro and in vivo
Lee, W., Ku, S., Kim, T. H., & Bae, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.061 · Cited by 28
Emodin affects ERCC1 expression in breast cancer cells
Fu, J., Zhou, J., Shi, J., Xie, J., Huang, L., Yip, A. Y., Loo, W. T., Chow, L. W., & Ng, E. L. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-s1-s7 · Cited by 22
Kong, X. B., Rubin, L. E., Chen, L. I., Ciszewska, G. R., Watanabe, K. A., Tong, W. P., Sirotnak, F. M., & Chou, T. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08865-0 · Cited by 21
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationEmodin: A Review of its Pharmacology, Toxicity and Pharmacokinetics
Dong, X., Fu, J., Yin, X., Cao, S., Li, X., Lin, L., Huyiligeqi, & Ni, J. (2016) · Phytotherapy Research · doi:10.1002/ptr.5631 · Cited by 762
Aloe‐emodin: A review of its pharmacology, toxicity, and pharmacokinetics
Dong, X., Zeng, Y., Liu, Y., You, L., Yin, X., Fu, J., & Ni, J. (2020) · Phytotherapy Research · doi:10.1002/ptr.6532 · Cited by 591
Medicinal Plants, Human Health and Biodiversity: A Broad Review
Sen, T., & Samanta, S. K. (2014) · Advances in Biochemical Engineering/Biotechnology · doi:10.1007/10_2014_273 · Cited by 330
M1 and M2 macrophage polarization and potentially therapeutic naturally occurring compounds
Wang, Y., Smith, W., Hao, D., He, B., & Kong, L. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.02.050 · Cited by 330
Metadata
- Authors
- Shrimali, D., Shanmugam, M. K., Kumar, A. P., Zhang, J., Tan, B. K. H., Ahn, K. S., & Sethi, G.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 341
- Issue
- 2
- Pages
- 139-149
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2007086998
- Cited by
- 277
- References
- 66
- FWCI
- 24.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.